P-S Medical CSF Access Dev 15MM/25MM
by Pudenz-Schulte Medical Research Corp.
510(k) K833822
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK833822 | Date25 May 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LKG
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.5550
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
This device is a Port & Catheter, Implanted, Subcutaneous, Intraventricular, as defined in the device data. It is designed for cerebrospinal fluid (CSF) access and is available in 15mm and 25mm sizes.
The device is supplied as an implanted system and is intended for use in neurology-related clinical settings. It received FDA 510(k) clearance under K833822 and is classified as a Class II medical device. No information regarding sterility, single-use or reusable status, MRI safety, storage conditions, or additional authorisations is provided in the data.
Other devices from Pudenz-Schulte Medical Research Corp.
See all devices from Pudenz-Schulte Medical Research Corp. →
Questions
AI-generated answers, 21 Sep 2026
What is the P-S MEDICAL CSF ACCESS DEV 15MM/25MM used for?
The device is designed for cerebrospinal fluid (CSF) access and is intended for use in neurology-related clinical settings as an implanted subcutaneous intraventricular port and catheter system.
What sizes are available for the P-S MEDICAL CSF ACCESS DEV 15MM/25MM?
The device is available in two sizes: 15mm and 25mm, as indicated in the product name and specifications, to accommodate different anatomical or clinical needs for CSF access.
How is the P-S MEDICAL CSF ACCESS DEV 15MM/25MM supplied and intended to be used?
The device is supplied as an implanted system and is intended for long-term subcutaneous placement to provide access to the ventricular system for cerebrospinal fluid management in neurology care.